XBP1 and early-onset autosomal dominant Alzheimer disease: Here we first briefly describe some aspects of XBP-1 biology and report on the experimental clues of its implication in various metabolic and inflammatory disorders as well as in several pathologies including cancer and neurodegenerative diseases such as amyotrophic lateral sclerosis, Huntington’s, Parkinson’s and Alzheimer’s diseases.